← Human Trials & Peer-Reviewed Studies
Effect of partial gastrectomy with Billroth II or Roux-en-Y anastomosis on postprandial and cholecystokinin-stimulated gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide
Plain-language guide to PMID 2390921 (1990): randomized controlled trial study of Pancreatic Polypeptide and Cholecystokinin (CCK) in 22 patients.
Key Facts
- PMID
- 2390921
- Journal
- Digestive diseases and sciences
- Year
- 1990
- Study type
- Randomized Controlled Trial
- Authors
- Rieu PN et al. (5 authors)
- DOI
- 10.1007/BF01537576
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Pancreatic Polypeptide and Cholecystokinin (CCK), published as a randomized controlled trial.
This prospective study was undertaken to determine the effect of partial gastrectomy without vagotomy on postprandial gallbladder contraction and secretion of cholecystokinin (CCK) and pancreatic polypeptide (PP) in 22 peptic ulcer patients randomly assigned to either Billroth II (N = 11) or Roux-en-Y (N = 11) anastomosis.
Why It Was Studied
After surgery basal gallbladder volumes were larger than preoperatively (P less than 0.02).
Who Took Part
The study group was 22 patients.
The age groups tagged for this paper are middle-aged adults, both men and women.
How the Study Was Run
In design terms this was a randomized study.
Because people in this Pancreatic Polypeptide study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
The methods mention a period of two weeks.
What Was Measured
Topics PubMed links to this paper include Anastomosis, Roux-en-Y, Cholecystokinin, Cholelithiasis, Food, Gallbladder, Gastrectomy and Jejunum.
What This Means in Plain Language
The paper is a randomized study of Pancreatic Polypeptide and Cholecystokinin (CCK) in 22 patients over two weeks.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 1990 (Digestive diseases and sciences), a journal based in United States.
More context: the Pancreatic Polypeptide compound page and the Cholecystokinin (CCK) compound page, all human trials.
Our Notes on the Compounds
Pancreatic Polypeptide: A 36-amino-acid pancreatic hormone in the same family as peptide YY and neuropeptide Y.
Cholecystokinin (CCK): A gut and brain peptide hormone that stimulates gallbladder contraction and signals fullness.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.